Oxford Genetics, a provider of synthetic based technologies for biologics discovery, development, and delivery, has entered a new licensing agreement with Twist Bioscience Corporation, a producer of rapid synthetic DNA. Under the deal, Oxford Genetics will supply Twist Bioscience with its SnapFast technology platform to provide a broad range of application-specific expression vectors, which Twist Bioscience will then use to clone synthesized DNA.
 

The SnapFast technology will allow Twist Bioscience to switch between all of Oxford Genetics’ vectors, making future changes and additions simple and efficient.

“By utilizing our SnapFast™ platform, Twist Bioscience is giving its customers access to the latest vector designs for the most demanding applications and providing them with better value, a streamlined workflow and maximum flexibility in order to utilize their custom DNA constructs to their best effect.” said Dr Ryan Cawood, chief executive officer of Oxford Genetics.